Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuya Matsue

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|December 21, 2022
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk scoreKai Ishii, Yuya Matsue, Katsumi Miyauchi, et al.
Scientific Reports|August 10, 2022
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factorsAkinori Higaki, Hideki Okayama, Yoshito Homma, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2023
Mixed-type Dyspnoea Diagnosed via Non-invasive and Invasive Cardiopulmonary Exercise TestsYuta Takamura, Tomohiro Kaneko, Nobuyuki Kagiyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2021
Prevalence and Prognostic Relevance of Isolated Tubular Dysfunction in Patients With Acute Heart FailureTaishi Dotare, Sayaki Ishiwata, Yuya Matsue, et al.
ESC Heart Failure|December 18, 2021
Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failureTsutomu Sunayama, Shoichiro Yatsu, Yuya Matsue, et al.
Journal of Cardiology|November 2, 2025
Prognostic value of the clinical phenotype in patients with cardiac sarcoidosis: SARCO phenotypeDaisuke Miyahara, Keisuke Kida, Takeru Nabeta, et al.
BMJ Open|September 9, 2021
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factorsShunsuke Kuroda, Shingo Matsumoto, Takahide Sano, et al.
The American Journal of Cardiology|November 9, 2016
Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular DiseaseKentaro Kamiya, Takashi Masuda, Yuya Matsue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 6, 2021
Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk FactorsShingo Matsumoto, Shunsuke Kuroda, Takahide Sano, et al.
Journal of Cardiac Failure|May 11, 2026
Bridging the Divide: Divergent Diagnostic Philosophies and Practice Pathways for Cardiac Sarcoidosis between Japan and North AmericaYuya Matsue, Daichi Maeda, Yudai Fujimoto, et al.
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
European Heart Journal. Quality of Care & Clinical Outcomes|December 21, 2022
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk scoreKai Ishii, Yuya Matsue, Katsumi Miyauchi, et al.
Scientific Reports|August 10, 2022
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factorsAkinori Higaki, Hideki Okayama, Yoshito Homma, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2023
Mixed-type Dyspnoea Diagnosed via Non-invasive and Invasive Cardiopulmonary Exercise TestsYuta Takamura, Tomohiro Kaneko, Nobuyuki Kagiyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2021
Prevalence and Prognostic Relevance of Isolated Tubular Dysfunction in Patients With Acute Heart FailureTaishi Dotare, Sayaki Ishiwata, Yuya Matsue, et al.
ESC Heart Failure|December 18, 2021
Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failureTsutomu Sunayama, Shoichiro Yatsu, Yuya Matsue, et al.
Journal of Cardiology|November 2, 2025
Prognostic value of the clinical phenotype in patients with cardiac sarcoidosis: SARCO phenotypeDaisuke Miyahara, Keisuke Kida, Takeru Nabeta, et al.
BMJ Open|September 9, 2021
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factorsShunsuke Kuroda, Shingo Matsumoto, Takahide Sano, et al.
The American Journal of Cardiology|November 9, 2016
Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular DiseaseKentaro Kamiya, Takashi Masuda, Yuya Matsue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 6, 2021
Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk FactorsShingo Matsumoto, Shunsuke Kuroda, Takahide Sano, et al.
Journal of Cardiac Failure|May 11, 2026
Bridging the Divide: Divergent Diagnostic Philosophies and Practice Pathways for Cardiac Sarcoidosis between Japan and North AmericaYuya Matsue, Daichi Maeda, Yudai Fujimoto, et al.
Pageof 25